Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Mar 01, 2007 (Vol. 27, No. 5)

Bioplanet

URL:www.bioplanet.com/index/php
  • Interesting mix of info
  • Ugly, weak in places
Billing itself as the “bioinformatics homepage,” BioPlanet could probably win some kind of an award for a gaudy opening page. From the cheap looking ringed planet to the visually unattractive mix of blue underlined links, orange headings, and occasional splashes of yellow for emphasis, beauty is more than skin deep here. There is a lot more to the site than the ugliness that meets the eye. Start with the job listings (over 1,400 jobs), resume listings (740), news links, stock market reports, and numerous forums, there is something here for almost anyone. The job listing was one place, however, where the delivery was a bit less than one might expect. Many of the jobs were simple writing opportunities with dreadful pay—$5–$8 per page. To be sure, there were some professional bioinformatics-related jobs, including several for programmers, but they were a small percentage of the 1,400 listed. All in all, BioPlanet hits in a few places and misses in a few others. It would not take much, however, to make this an outstanding site, so I hope the developers will keep working on it.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »